Work

Digging Deeper with Allogeneic Transplantation in Multiple Myeloma

Year: 2013

Type: article

Abstract: The treatment paradigms for myeloma have dramatically changed in the past decade with availability of more effective drugs, and patients are living substantially longer [1]. These changes, along with a better understanding of the genetic underpinnings of the disease, have changed our approach to management of patients with myeloma. The study by Kroger and colleagues [2] highlights two of the most debated questions in myeloma today: What should be the goal of myeloma therapy and how do we approach patients with high-risk multiple myeloma?

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2012.12.020

Author: Shaji K. Kumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650